Skip to content

Corpus Callosum Size in Patients With Pineal Cyst

Corpus Callosum Size in Patients With Pineal Cyst

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03183427
Enrollment
200
Registered
2017-06-12
Start date
2017-09-30
Completion date
2018-09-30
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Corpus Callosum Atrophy, Pineal Gland Disorder

Brief summary

This study aims to determine size of corpus callosum on midsagittal MR scan in patients with a pineal cyst and to compare it with the control group without a pineal cyst.

Detailed description

A pineal cyst (PC) is a benign affection of the pineal gland, its prevalence in population reaches 1-2 %. Etiopathogenesis of PC is unknown, several hypotheses have been proposed. One of the hypothesis consider perinatal hypoxia as a causative factor for a development of PC in later life. Ozmen et al. showed significantly higher prevalence of PC in patients with cerebral palsy (p\<0.001). Bregant et al. studied presence of PC in patients that suffered from a mild to moderate perinatal hypoxia. Prevalence of PC reached 36 % in these patients and presence of PC was associated with a atrophy of the corpus callosum (p\<0.005). The atrophy of the corpus callosum is considered to be a sign of a periventricular leukomalacia, i.e. an ischemic insult in a perinatal period. In the present study, we are going to compare an area of corpus callosum on a midsagittal magnetic resonance T2-weighted scan in the group of patients with PC and in the control group without PC. The goal of the study is to determine if there is a relationship between atrophy of the corpus callosum and PC. Such finding would support abovementioned theory of etiopathogenesis of PC.

Interventions

DIAGNOSTIC_TESTMR of the brain

MR of the brain without gadolinium, incl. T2-weighted image

Sponsors

Military University Hospital, Prague
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* 3T MR examination of the brain including T2 sagittal scans

Exclusion criteria

* other intracranial pathology discovered on the MR * other known neurological disease (e.g. multiple sclerosis, stroke, tumor, etc.)

Design outcomes

Primary

MeasureTime frameDescription
size of corpus callosumtime of the MR examinationsize of corpus callosum in mm2 measured on the midsagittal T2-weighted MR scan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026